These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Low dose hexarelin and growth hormone (GH)-releasing hormone as a diagnostic tool for the diagnosis of GH deficiency in adults: comparison with insulin-induced hypoglycemia test. Gasperi M, Aimaretti G, Scarcello G, Corneli G, Cosci C, Arvat E, Martino E, Ghigo E. J Clin Endocrinol Metab; 1999 Aug; 84(8):2633-7. PubMed ID: 10443652 [Abstract] [Full Text] [Related]
26. Administration of arginine plus growth hormone releasing hormone to evaluate growth hormone (GH) secretory status in children with GH deficiency. Keller A, Donaubauer J, Kratzsch J, Pfaeffle R, Hirsch W, Kiess W, Keller E. J Pediatr Endocrinol Metab; 2007 Dec; 20(12):1307-14. PubMed ID: 18341090 [Abstract] [Full Text] [Related]
27. New approach to the diagnosis of growth hormone deficiency in adults. Ghigo E, Aimaretti G, Gianotti L, Bellone J, Arvat E, Camanni F. Eur J Endocrinol; 1996 Mar; 134(3):352-6. PubMed ID: 8616534 [Abstract] [Full Text] [Related]
28. GHRH plus arginine and arginine administration evokes the same ratio of GH isoforms levels in young patients with Prader-Willi syndrome. Rigamonti AE, Crinò A, Bocchini S, Convertino A, Bidlingmaier M, Haenelt M, Tamini S, Cella SG, Grugni G, Sartorio A. Growth Horm IGF Res; 2018 Apr; 39():13-18. PubMed ID: 29217318 [Abstract] [Full Text] [Related]
29. The Cut-off Limits of Growth Hormone Response to the Insulin Tolerance Test Related to Body Mass Index for the Diagnosis of Adult Growth Hormone Deficiency. Gasco V, Ferrero A, Bisceglia A, Prencipe N, Cambria V, Bioletto F, Ghigo E, Maccario M, Grottoli S. Neuroendocrinology; 2021 Apr; 111(5):442-450. PubMed ID: 32335555 [Abstract] [Full Text] [Related]
30. Can a glucagon stimulation test characterized by lower GH cut-off value be used for the diagnosis of growth hormone deficiency in adults? Diri H, Karaca Z, Simsek Y, Tanriverdi F, Unluhizarci K, Selcuklu A, Kelestimur F. Pituitary; 2015 Dec; 18(6):884-92. PubMed ID: 26129876 [Abstract] [Full Text] [Related]
31. Impairment of GH secretion in adults with primary empty sella. Gasperi M, Aimaretti G, Cecconi E, Colao A, Di Somma C, Cannavò S, Baffoni C, Cosottini M, Curtò L, Trimarchi F, Lombardi G, Grasso L, Ghigo E, Martino E. J Endocrinol Invest; 2002 Apr; 25(4):329-33. PubMed ID: 12030603 [Abstract] [Full Text] [Related]
32. The usefulness of the combined growth hormone (GH)-releasing hormone and arginine stimulation test in the diagnosis of radiation-induced GH deficiency is dependent on the post-irradiation time interval. Darzy KH, Aimaretti G, Wieringa G, Gattamaneni HR, Ghigo E, Shalet SM. J Clin Endocrinol Metab; 2003 Jan; 88(1):95-102. PubMed ID: 12519836 [Abstract] [Full Text] [Related]
33. Gender differences in GH response to GHRH+ARG in lipodystrophic patients with HIV: a key role for body fat distribution. Brigante G, Diazzi C, Ansaloni A, Zirilli L, Orlando G, Guaraldi G, Rochira V. Eur J Endocrinol; 2014 May; 170(5):685-96. PubMed ID: 24536088 [Abstract] [Full Text] [Related]
34. The diagnosis of GH deficiency in obese patients: a reappraisal with GHRH plus arginine testing after pharmacological blockade of lipolysis. Scacchi M, Orsini F, Cattaneo A, Grasso A, Filippini B, Pecori Giraldi F, Fatti LM, Moro M, Cavagnini F. Eur J Endocrinol; 2010 Aug; 163(2):201-6. PubMed ID: 20460421 [Abstract] [Full Text] [Related]
35. GH response to GHRH combined with pyridostigmine or arginine in different conditions of low somatotrope secretion in adulthood: obesity and Cushing's syndrome in comparison with hypopituitarism. Procopio M, Maccario M, Savio P, Valetto MR, Aimaretti G, Grottoli S, Oleandri SE, Baffoni C, Tassone F, Arvat E, Camanni F, Ghigo E. Minerva Endocrinol; 1999 Aug; 24(3-4):107-11. PubMed ID: 10953725 [Abstract] [Full Text] [Related]
36. Prevalence of GH and other anterior pituitary hormone deficiencies in adults with nonsecreting pituitary microadenomas and normal serum IGF-1 levels. Yuen KC, Cook DM, Sahasranam P, Patel P, Ghods DE, Shahinian HK, Friedman TC. Clin Endocrinol (Oxf); 2008 Aug; 69(2):292-8. PubMed ID: 18221393 [Abstract] [Full Text] [Related]
37. Macimorelin (AEZS-130)-stimulated growth hormone (GH) test: validation of a novel oral stimulation test for the diagnosis of adult GH deficiency. Garcia JM, Swerdloff R, Wang C, Kyle M, Kipnes M, Biller BM, Cook D, Yuen KC, Bonert V, Dobs A, Molitch ME, Merriam GR. J Clin Endocrinol Metab; 2013 Jun; 98(6):2422-9. PubMed ID: 23559086 [Abstract] [Full Text] [Related]
38. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY DISEASE STATE CLINICAL REVIEW: UPDATE ON GROWTH HORMONE STIMULATION TESTING AND PROPOSED REVISED CUT-POINT FOR THE GLUCAGON STIMULATION TEST IN THE DIAGNOSIS OF ADULT GROWTH HORMONE DEFICIENCY. Yuen KC, Tritos NA, Samson SL, Hoffman AR, Katznelson L. Endocr Pract; 2016 Oct; 22(10):1235-1244. PubMed ID: 27409821 [Abstract] [Full Text] [Related]
39. Diagnostic reliability of a single IGF-I measurement in 237 adults with total anterior hypopituitarism and severe GH deficiency. Aimaretti G, Corneli G, Baldelli R, Di Somma C, Gasco V, Durante C, Ausiello L, Rovere S, Grottoli S, Tamburrano G, Ghigo E. Clin Endocrinol (Oxf); 2003 Jul; 59(1):56-61. PubMed ID: 12807504 [Abstract] [Full Text] [Related]